Jeffrey V. Poulton's Net Worth
$4.67 Million
Who is Jeffrey V. Poulton?
Jeffrey V. Poulton has an estimated net worth of $4.67 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., Homology Medicines, Inc., and CervoMed Inc..
SEC CIK
Jeffrey V. Poulton's CIK is 0001782962
Past Insider Trading and Trends
2023 was Jeffrey V. Poulton's most active year for acquiring shares with 7 total transactions. Jeffrey V. Poulton's most active month to acquire stocks was the month of January. 2023 was Jeffrey V. Poulton's most active year for disposing of shares, totalling 11 transactions. Jeffrey V. Poulton's most active month to dispose stocks was the month of July. 2020 saw Jeffrey V. Poulton paying a total of $2,898,599.70 for 60,573 shares, this is the most they've acquired in one year. In 2022 Jeffrey V. Poulton cashed out on 5,054 shares for a total of $968,823.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $168.81
EVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.15% | 1.67K |
$231.00 | -$370,747.09 | 28.89K |
Jun 24 - Jun 25
| |||
Form 4
| +39.74% | 7.74K |
—
|
—
| 27.22K |
Mar 1
| |||
Form 4
| +7.35% | 1.33K |
$155.30 | -$89,144.57 | 19.48K |
Feb 27 - Feb 28
| |||
Form 4
| +14.31% | 2.27K |
$148.06 | -$149,099.42 | 18.14K |
Feb 15 - Feb 16
| |||
Form 4
| +35.60% | 4.17K |
$185.85 | -$643,036.64 | 15.87K |
Aug 3 - Aug 4
| |||
Form 4
| +24.45% | 2.3K |
$194.59 | -$190,113.44 | 11.71K |
Apr 26 - Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +200.03% | 6.27K |
$191.69 | -$968,823.92 | 9.41K |
Aug 3 - Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 3.17K |
$131.85 | -$182,347.25 | 3.17K |
Oct 10 - Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
∞
| 19 |
—
|
—
| 19 |
Jan 3 - Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) Snapshot price: $0.7151
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CervoMed Inc. (CRVO) Snapshot price: $9.08
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||